NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Windward Bio

Windward Bio

Private
BaselHealthcare & Life Scienceshttps://windwardbio.com/

Last Round

VC Round

May 4, 2026

Total Funding Raised

$200M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Windward Bio is a biotechnology company that develops long-acting antibody therapies for immunological, respiratory, and dermatological diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B2C

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

long-acting antibodiesmonoclonal antibodymAbTSLP inhibitorextended-dosing biologicsimmunologybiopharmabispecific antibodyclinical-stage biotechasthma therapyCOPD therapybiologicsTSLP x IL-13 bispecificdrug in-licensingsubcutaneous injectiondermatology therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Windward Bio Comps

Public and private peers based on sector, stage, and business model.

Windward Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Windward Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 4, 2026
Series AJan 10, 2025
View all Funding Rounds

Key People

Founding team and executive leadership

Luca Santarelli

Founder, CEO And Chairman

Founding Team

Teit Agger

Chief Technology Officer

Executive Team

Claudia D'Augusta

Group CFO

Executive Team

Windward Bio Investors

Notable investors and investment history

Windward Bio investors
InvestorRounds
Janus Henderson GroupVC Round
RA Capital ManagementVC Round
Omega FundsVC Round, Series A
Blue Owl CapitalVC Round
OrbiMedVC Round, Series A
Novo HoldingsVC Round, Series A
Sanofi VenturesVC Round
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors increased 68% MoM.

  • May 4, 2026

    $165M round led by OrbiMed.

View all signals

Windward Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Windward Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Windward Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBasel
Employee Range46
Year Founded2024
Last FundingMay 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.